The $12.7 Million Medicaid Scheme That Turned Recovery Into Revenue

In just a matter of hours, federal officials announced what they described as the largest healthcare fraud takedown in U.S. history—more than 300 defendants charged in schemes totaling over $14 billion in alleged fraud. But buried inside that massive national crackdown was one North Carolina case that stood out for a different reason: prosecutors say it did not just misuse public money. It preyed on people who were already struggling to reclaim their lives.

According to investigators, a substance abuse treatment operation tied to a church-based organization in Kinston and Goldsboro, North Carolina, became the center of a years-long Medicaid fraud scheme worth more than $12.7 million in fraudulent billings. The people at the center of the case, authorities say, built a system that depended on vulnerable patients returning again and again—not because they were getting meaningful treatment, but because every visit, every test, and every routine interaction could be turned into another billable claim.

What made the allegations especially disturbing, prosecutors said, was the method used to keep patients coming back. Court filings and investigators describe a setup in which patients were allegedly offered gift cards based on how many outpatient substance abuse meetings they attended each week. In a program supposedly designed to help people break free from addiction, officials say those incentives may have done the opposite.

And once investigators started tracing where the Medicaid money went, they say the picture became even darker.

The case centers on Life Touch, a company formed in 2009 that provided substance abuse services to Medicaid recipients in eastern North Carolina. Prosecutors say the operation ran for roughly five years and involved Brandon Sims, along with members of his family and senior staff. According to the government, the business was managed by a tight circle: Sims; his mother, Francine Sims Super, who helped run the company; his sister, Kimberly Sims, who owned a drug testing lab called First Choice Medical Healthcare; and staff member Kiki Johnson, who handled billing and compliance.

On paper, the structure looked legitimate enough. One company offered treatment. Another handled drug testing. Patients came in, participated in services, and the providers billed Medicaid. That, after all, is how many healthcare businesses operate.

But prosecutors say this operation was never really about treatment.

Instead, investigators allege, it was about building a dependable patient pool and extracting as much Medicaid money as possible from it. The people targeted, according to officials, were often financially strained and already in need of help. Some were individuals battling alcohol or drug dependency. Others, investigators said, included members of immigrant communities from places such as Syria and Afghanistan—people who may have been especially vulnerable to manipulation, confusion, or economic pressure.

The government’s theory is simple and devastating: once those patients were inside the system, they became a source of recurring revenue.

Authorities say patients were offered gift cards depending on attendance. Under the structure described by investigators, a patient who attended five meetings in a week could receive a $60 gift card. Four visits could earn $50. Three visits could earn $45. What that allegedly created was a routine—one that encouraged people to keep returning, whether or not the services being provided were medically necessary or effective.

In many fraud cases, the mechanics are dry: paperwork, invoices, back-office billing. This one, prosecutors argue, was more personal. The alleged incentives were handed directly to people already wrestling with addiction and instability. According to investigators, evidence suggested that some patients used those gift cards to buy drugs, effectively feeding the very cycle the treatment center claimed it existed to disrupt.

That detail changed the moral weight of the case.

Officials did not describe it as a simple accounting scam. They described it as a scheme in which addiction itself became part of the business model. If a patient remained trapped, the system kept producing claims. If the patient returned week after week, more services could be billed. If more tests were ordered, more money could flow.

For prosecutors, the implication was hard to ignore: the operation allegedly had a financial reason not to solve the problem at the heart of its business.

Federal officials were blunt about that point. They said the scheme exploited people who were not only poor or struggling, but already trying to recover some sense of stability and dignity. Rather than receiving care that might move them toward sobriety, investigators say many of them were drawn into a cycle that enriched the people running the program.

The clinic, prosecutors say, was only one half of the machinery.

The second stream of income allegedly came from First Choice Medical Healthcare, the drug testing lab tied to the same family. The lab was registered as a separate business, with Kimberly Sims listed as the sole owner. On the surface, that separation may have made the arrangement look ordinary. But as investigators began comparing financial records, billing patterns, and profit distributions, they say troubling links emerged.

According to prosecutors, patients who came through Life Touch were routinely sent to the lab for drug screens. Every test, of course, could be billed. And as fraud investigators have noted in case after case, lab testing can become a lucrative point of abuse when providers order repeated or unnecessary screens that do little to change patient care.

That is what officials say happened here.

Patients were allegedly tested over and over, with little meaningful connection between the volume of testing and the quality of treatment being delivered. The results themselves, investigators suggested, mattered less than the billing opportunity. If a patient remained in the system, another test could be justified. If the patient came back again, more services could be attached. One stream fed the other.

The government says the profit-sharing arrangement revealed just how interconnected the businesses really were. Prosecutors alleged that Kimberly Sims, Francine Sims Super, and Kiki Johnson split profits from First Choice billings tied to Life Touch patients in roughly equal shares. Court filings reportedly showed Francine Sims Super receiving more than $400,000 from the lab and Johnson also receiving more than $400,000.

The allegation was not just that Medicaid had been billed improperly. It was that an entire ecosystem had been built around maximizing reimbursement from vulnerable people who were supposed to be receiving help.

By the time federal authorities finished tracing the clinic claims and the lab claims together, they said the scale of the scheme had become undeniable. Prosecutors tied at least $12.7 million in fraudulent Medicaid billings directly to the operation. Court records also indicated that over the life of the scheme, Life Touch may have received as much as $25 million in North Carolina Medicaid proceeds.

That figure raised the next obvious question: if the money was not going into real treatment, where did it go?

Investigators say the answer led them far beyond the clinic.

Brandon Sims, according to prosecutors, received millions in proceeds from the operation, much of it moving directly into his bank accounts. When scrutiny began to intensify, officials say the money started to move. Large withdrawals were made. Cash was pulled out of the banking system. And once that happens, investigators know the trail becomes harder to follow.

Still, they followed it.

When authorities executed a search warrant at Sims’ home in Texas, they say they found $1.3 million in cash inside a safe. Not hidden in a complex offshore structure. Not buried behind layers of shell companies. Just cash, broken down into smaller bills, sitting in a place investigators say made clear how much money had already been removed from formal financial channels.

That discovery was dramatic, but officials made clear it was only part of the story.

Investigators also identified a series of luxury assets allegedly tied to the scheme’s proceeds, including a 2021 Rolls-Royce Cullinan, a Corvette, a Silverado, real estate, and other high-value property. To prosecutors, those purchases helped tell a familiar story: public healthcare money going out one side of the system and reappearing on the other as lifestyle wealth.

Even so, officials acknowledged that they were unlikely to recover everything.

Once large amounts of cash are withdrawn and scattered, the paper trail weakens. Federal authorities said they expected to recover around $8 million through asset forfeiture—significant by any measure, but still well short of the total amount allegedly stolen. In a case involving tens of millions of dollars, even getting back more than half, one official suggested, can count as a victory.

That is one of the bitter truths at the heart of fraud cases like this. By the time the scheme is fully exposed, much of the damage has already been done. The money has moved. The records have been shaped to look routine. The patients have already been used. And the public programs that are supposed to serve people in genuine need have already absorbed the loss.

Then came the tax trail.

According to court records, Brandon Sims also failed to report millions in income linked to the operation, triggering IRS involvement. That expanded the case beyond healthcare fraud and into tax-related charges tied to false filings and undeclared income. Once investigators linked the money to bank records, withdrawals, vehicles, and properties, the government had a stronger basis to seize assets and demand repayment.

In the end, prosecutors pursued not only restitution to Medicaid but also repayment to the IRS.

The sentences that followed reflected the seriousness with which federal authorities viewed the case. Brandon Sims received 30 months in prison, according to the information provided. Francine Sims Super, Kimberly Sims, and Kiki Johnson also faced tax-related charges and prison terms, with sentences ranging from 30 months to six years. In addition, the defendants were ordered to repay millions, including more than $2 million to the IRS.

For law enforcement, the case became a warning. Exploiting Medicare and Medicaid, officials said, is not a low-risk shortcut to easy money. Investigators will follow the billing, trace the accounts, identify the assets, and push for both prison time and financial recovery.

But even that message does not fully capture what makes this case linger.

At the center of it were not abstract line items. They were people who came into a substance abuse program because they needed help, structure, or hope. Some may have believed they were entering a place built for recovery. Instead, according to prosecutors, they became part of a mechanism designed to generate claims.

That is why this case resonated beyond the dollar figures. It was not only about waste, fraud, or abuse in the bureaucratic sense. It was about the conversion of human vulnerability into billable revenue. It was about a system that, according to the government, was easy enough to manipulate that it could operate for years before collapsing under scrutiny.

The broader question now is whether prosecutions alone are enough.

Fraud schemes of this kind do not survive only because a few people are willing to break the law. They survive because the structure around them can be exploited—because repeated testing can be billed, because attendance can be monetized, because oversight often lags behind paperwork that appears normal on its face. By the time red flags become obvious, the money is often already gone.

That leaves policymakers and the public facing a harder conversation. Is it enough to punish the people who built this operation? Or does the system itself need to change if the goal is to stop the next version of the same fraud from taking root somewhere else?

The federal crackdown announced in recent hours may go down as the largest in U.S. history by the numbers. Yet cases like this one are a reminder that the real damage cannot be measured in indictments alone. It can also be found in every treatment seat that became a revenue source, every test that allegedly served billing more than care, and every patient whose struggle was turned into someone else’s business plan.

That is what makes this North Carolina case so difficult to forget.

It was not just a fraud case.

According to prosecutors, it was a case about what happens when a system built to heal becomes, in the hands of the wrong people, a machine for extraction. And by the time federal agents finally shut it down, the losses were not only financial. They were human, institutional, and painfully hard to reverse.